Mar 18, 2021

A new method for analyzing silenced genes

Cancers are diseases of the genome. They can result from minor changes to single or a few base pairs, known as mutations, or from larger structural changes to the genome, including how it is packaged into chromosomes and manipulated by other molecules. Understanding how things have gone wrong in specific cancers can help scientists develop better prognostic tools and treatment strategies.

Feb 11, 2021

New study provides insight into the molecular biology of colorectal cancer

In a new study published in the journal Cancer Biology & Therapy, Dr. Tai’s research group characterized the involvement of a multi-functional protein, called NPM1, in colorectal cancer growth and treatment resistance, providing the research community with a potential therapeutic target for the treatment of the disease.
Feb 04, 2021

World Cancer Day 2021

February 4 is World Cancer Day—a global initiative led by the Union for International Cancer Control. Patients, families, communities, clinicians, researchers and others are joining together to raise awareness and to act.

Here at Canada’s Michael Smith Genome Sciences Centre at BC Cancer, we are making significant strides in realizing the benefit of genomics in researching, understanding, diagnosing and treating cancer.

Feb 02, 2021


Our first petabase of sequencing data was recorded in December of 2015, 16 years from the creation of the GSC in 1999. In April of 2018, just two years and four months later, we recorded our second.  On Sunday, January 24, 2021 we hit another milestone—three petabases of sequencing data!
Jan 07, 2021

Molecular subtypes of common pancreatic cancers can be predicted from tumour characteristics

Gene expression analysis of pancreatic ductal adenocarcinoma (PDAC) tumours enables clinicians to stratify patients into molecular subgroups and select treatments that are best suited to each type; however, molecular subtyping remains cost-prohibitive and is not yet part of routine cancer care.

Back to top